Filter Results:
(1,008)
Show Results For
- All HBS Web
(1,008)
- People (3)
- News (261)
- Research (631)
- Events (1)
- Multimedia (6)
- Faculty Publications (295)
Show Results For
- All HBS Web
(1,008)
- People (3)
- News (261)
- Research (631)
- Events (1)
- Multimedia (6)
- Faculty Publications (295)
- 06 Dec 2021
- News
Action Plan: Whole Sale
The future of retail won’t be brick and mortar or online, says Musab Balbale (MBA 2007). Instead, it will be a more inclusive combination of the two. Balbale, who spent several years of his career focused exclusively on online sales, is... View Details
- June 2016
- Article
Vaccination Rates Are Associated with Functional Proximity but Not Base Proximity of Vaccination Clinics
By: John Beshears, James J. Choi, David Laibson, Brigitte C. Madrian and Gwendolyn I. Reynolds
Background: Routine annual influenza vaccinations are recommended for persons 6 months of age and older, but less than half of U.S. adults get vaccinated. Many employers offer employees free influenza vaccinations at workplace clinics, but even then take-up is... View Details
Beshears, John, James J. Choi, David Laibson, Brigitte C. Madrian, and Gwendolyn I. Reynolds. "Vaccination Rates Are Associated with Functional Proximity but Not Base Proximity of Vaccination Clinics." Medical Care 54, no. 6 (June 2016): 578–583.
- July 2000 (Revised August 2005)
- Case
Deaconess-Glover Hospital (A)
Chronicles the initial efforts to teach a health care organization to manage itself according to the principles of the Toyota Production System (TPS). Describes the decision and dilemmas that arose from the implementation experiment. Builds on Bowen and Spear's earlier... View Details
Spear, Steven J., and John Kenagy. "Deaconess-Glover Hospital (A)." Harvard Business School Case 601-022, July 2000. (Revised August 2005.)
- 01 Jun 2002
- News
Profile: The Invisible Hand - Robert Massie and God's Green Earth
Seated in his office near Boston's Public Garden, he recollects sunlit summers in Maine (where his love for the natural world flourished) and his family's four-year sojourn in Paris (where, as a teenager, he received state-of-the-art... View Details
- Research Summary
Health-care Applications
Active postmarketing drug surveillance. There is substantial interest within the U.S. health community and among health policymakers in developing a surveillance system that scans public health databases in order to proactively detect potential drug safety... View Details
- 11 Oct 2024
- Research & Ideas
How AI Could Ease the Refugee Crisis and Bring New Talent to Businesses
difficult.” “It’s not like it’s a one-size-fits-all solution that we can apply to every country.” With the pilot tests underway, Paulson and Bansak are hopeful that the US and... View Details
- July 1998
- Supplement
Bell Atlantic in Union City
In this pioneering project to wire a school for the Internet and put computers in students' homes, Bell Atlantic combined its need for a beta site for a technology trial with the school reform efforts of the Union City, New Jersey public schools, under the leadership... View Details
Keywords: Business Model; Social Enterprise; Internet and the Web; Education; Business and Community Relations; Education Industry; New Jersey
Kanter, Rosabeth M. "Bell Atlantic in Union City." Harvard Business School Video Supplement 399-501, July 1998.
- January 2023
- Case
Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery
By: Regina Herzlinger and Brian Walker
What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details
Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry
Herzlinger, Regina, and Brian Walker. "Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery." Harvard Business School Case 323-045, January 2023.
- 2022
- Working Paper
Causal Inference During A Pandemic: Evidence on the Effectiveness of Nebulized Ibuprofen as an Unproven Treatment for COVID-19 in Argentina
By: Sebastian Calonico, Rafael Di Tella and Juan Cruz Lopez Del Valle
Many medical decisions during the pandemic were made without the support of causal evidence obtained in clinical trials. We study the case of nebulized ibuprofen (NaIHS), a drug that was extensively used on COVID-19 patients in Argentina amidst wild claims about its... View Details
Keywords: COVID-19; Drug Treatment; Health Pandemics; Health Care and Treatment; Decision Making; Outcome or Result; Argentina
Calonico, Sebastian, Rafael Di Tella, and Juan Cruz Lopez Del Valle. "Causal Inference During A Pandemic: Evidence on the Effectiveness of Nebulized Ibuprofen as an Unproven Treatment for COVID-19 in Argentina." NBER Working Paper Series, No. 30084, May 2022.
- June 2016
- Teaching Plan
Terrapin Laboratory
By: Joseph B. Fuller and Andrew Otazo
This teaching plan accompanies the case "Terrapin Laboratory," HBS No. 315-098. That case describes the formation and rapid growth of a drug testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug... View Details
- February 2022
- Case
Leading The UK Vaccine Task Force
By: Amy C. Edmondson and Claudia Pienica
This case describes the first six months of the UK Vaccine Taskforce, under the leadership of Kate Bingham. With a career spent in the private sector as a biotech investor, Bingham’s appointment within the government was considered unusual. The overarching brief given... View Details
Keywords: COVID-19; Vaccine; Government; Health Pandemics; Health Care and Treatment; Science; Innovation and Invention; Groups and Teams; Leadership; Decision Making; Government and Politics; Health; Innovation and Management; Governance; Change; Government Administration; Health Industry; Health Industry; Health Industry; Europe; United Kingdom
Edmondson, Amy C., and Claudia Pienica. "Leading The UK Vaccine Task Force." Harvard Business School Case 622-079, February 2022.
- 13 Mar 2019
- News
The First Five Years: Sierra Smith and Taylor Wiegele (both MBA 2017)
(but growing!) company, which means that every day is a new adventure. On the ‘typical’ side, there are the must-dos: order fulfillment, customer service, and paying the bills. Beyond that, on any given day we could be negotiating with a... View Details
- 20 Jun 2019
- News
What Tech Pioneers Can Learn From Emerging Markets
- 09 Nov 2023
- Blog Post
The No. 1 Character Trait You Will Need to Succeed in Business
If you choose to pursue a career in business, I can guarantee that you will experience moments that will test you as never before. At times like those, what quality will you need more than any other? I believe that quality is courage.... View Details
- 15 Dec 2015
- News
The Year in Ideas 2015
create informed, online test prep through Khan Academy. Free, accessible coaching, Khan reasons, will help “level the playing field”—giving every student, everywhere access to elite-level SAT coaching. J.R. Simplot’s White Russet is... View Details
- October 2006 (Revised August 2007)
- Case
Calloway Laboratory: Pee for Profit
By: Richard G. Hamermesh and David Kiron
Describes the formation and rapid growth of a drug-testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. View Details
Keywords: For-Profit Firms; Health Care and Treatment; Health Testing and Trials; Growth and Development Strategy; Market Entry and Exit; Health Industry
Hamermesh, Richard G., and David Kiron. "Calloway Laboratory: Pee for Profit." Harvard Business School Case 807-040, October 2006. (Revised August 2007.)
- Research Summary
Overview
I am currently a Principal or Co-Principal Investigator of five field-based randomized controlled trials, each of which examines the management of lay health workers in developing countries, with an eye toward generating theoretical insights and policy guidance on how... View Details
- Research Summary
Overview
I am currently a Principal or Co-Principal Investigator of five field-based randomized controlled trials, each of which examines the management of lay health workers in developing countries, with an eye toward generating theoretical insights and policy guidance on how... View Details
- Research Summary
Overview
I am currently a Principal or Co-Principal Investigator of five field-based randomized controlled trials, each of which examines the management of lay health workers in developing countries, with an eye toward generating theoretical insights and policy guidance on how... View Details
- Article
Physician-Induced Demand for Medical Care
By: Jerry R. Green
This paper addresses the theoretical models designed to ascertain the existence of a variable level of physicians' activity in shifting the demand of their patients. Two basic approaches are followed: equilibrium models of the demand for health care, and disequilibrium... View Details
Keywords: Physicians; Economic Equilibrium; Monopolistic Competition; Economic Competition; Medical Care
Green, Jerry R. "Physician-Induced Demand for Medical Care." Special Issue on National Bureau of Economic Research Conference on the Economics of Physician and Patient Behavior. Journal of Human Resources 13, Suppl. (1978).